Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets. Find out which is the better bargain ...

After starting 2024 strong, Eli Lilly (NYSE: LLY) did not perform well in the second half of last year. Its financial results ...

(Bloomberg) -- Eli Lilly & Co.’s Alzheimer’s disease drug Kisunla failed to get the backing of European regulators, who said its benefits don’t outweigh the risk of potentially fatal bleeding in the ...

We recently published a list of Billionaire Ken Fisher’s Top 13 Growth Stock Picks. In this article, we are going to take a ...

Trump’s Not-So-Subtle Purpose in Fighting Big Law Firms President Trump has attacked law firms for “frivolous” litigation. But his actions could undermine the basic right of Americans to sue ...

The phone rang over the whine of Trey Yates' butter churn. The person calling was polite, but the message was devastating: Mountaineer Food Bank was ending Yates' butter contract, due to the ...